Guru Nanak Hospital & Research Centre Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 07-01-2025
- Paid Up Capital ₹ 2.94 M
as on 07-01-2025
- Company Age 21 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.09 Cr
as on 07-01-2025
- Revenue 21.07%
(FY 2022)
- Profit 81.61%
(FY 2022)
- Ebitda -91.70%
(FY 2022)
- Net Worth 13.20%
(FY 2022)
- Total Assets -5.62%
(FY 2022)
About Guru Nanak Hospital & Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 2.94 M.
The company currently has active open charges totaling ₹4.09 Cr.
Karan Singh, Rajender Kour, and Nirmal Singh serve as directors at the Company.
- CIN/LLPIN
U85110WB2003PTC095774
- Company No.
095774
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Feb 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Puruliya, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Guru Nanak Hospital & Research Centre?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karan Singh  | Director | 29-Aug-2018 | Current |
| Rajender Kour | Director | 20-Feb-2003 | Current |
| Nirmal Singh | Director | 20-Feb-2003 | Current |
Financial Performance of Guru Nanak Hospital & Research Centre.
Guru Nanak Hospital & Research Centre Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.07% increase. The company also saw a substantial improvement in profitability, with a 81.61% increase in profit. The company's net worth Soared by an impressive increase of 13.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Guru Nanak Hospital & Research Centre?
In 2021, Guru Nanak Hospital & Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
P. J. Nirman Private LimitedActive 25 years 27 daysKaran Singh, Rajender Kour and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Jan 2024 | ₹5.41 M | Open |
State Bank Of India Creation Date: 30 Oct 2013 | ₹3.00 Cr | Open |
State Bank Of India Creation Date: 15 Nov 2003 | ₹5.50 M | Open |
How Many Employees Work at Guru Nanak Hospital & Research Centre?
Unlock and access historical data on people associated with Guru Nanak Hospital & Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Guru Nanak Hospital & Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Guru Nanak Hospital & Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
